Billiontoone Inc Net Income per Employee (BLLN), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Billiontoone Inc   (NASDAQ: BLLN)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Billiontoone Inc Net Income per Employee

BLLN's Quarterly Results, Trends, Rankings, Statistics
Billiontoone Inc 's Income per employee grew in the first quarter 2026 on a trailing twelve month basis to $ 611,935, the income was higher than average, indicating higher productivity of the company's employees.
The Healthcare sector has seen Billiontoone Inc achieved the highest income per employee. While income per employee total ranking has improved so far to , from total ranking in previous quarter at 1.


What is Income per Employee Ratio?






BLLN Net Income per Employee (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Mar 31 2025)
I. Quarter
(Sep 30 2024)
III. Quarter
Y / Y Net Income Change -95.56 % - - - -
Net Income per Employee (TTM) $ 611,935 1,154,060 1,152,080 1,149,966 567,328
BLLN's Total Ranking # # 1 # 2313 # #
Seq. Net Income Change 1172.66 % -6.3 % -99.64 % 2.7 % -


BLLN Net Income per Employee Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall Market #

Net Income per Employee Statistics
High Average Low
$ 2,114 $ 2,114 $ 2,114
(Sep 30 2025)  







Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026
Ironwood Pharmaceuticals inc   1,021,760.00 $ 102.176  Million 100 
Silexion Therapeutics Corp  922,142.86 $ 12.910  Million 14 
United Therapeutics Corporation  919,571.43 $ 1,287.400  Million 1,400 
Emmis Acquisition Corp   906,895.50 $ 1.814  Million
Halozyme Therapeutics Inc   824,687.94 $ 348.843  Million 423 
Prestige Consumer Healthcare Inc   785,608.77 $ 447.797  Million 570 
Agenus Inc  771,518.52 $ 62.493  Million 81 
Krystal Biotech Inc   762,813.56 $ 225.030  Million 295 
Elite Pharmaceuticals Inc   690,349.02 $ 44.873  Million 65 
Illumina Inc   666,406.25 $ 853.000  Million 1,280 
Engene Therapeutics Inc   623,048.78 $ 51.090  Million 82 
Spero Therapeutics Inc   609,400.00 $ 15.235  Million 25 
Amgen Inc   600,000.00 $ 7,800.000  Million 13,000 
Vaxart Inc   570,723.08 $ 37.097  Million 65 
Entera Bio Ltd   562,590.91 $ 12.377  Million 22 
Gilead Sciences Inc   542,117.65 $ 9,216.000  Million 17,000 
Soleno Therapeutics Inc  527,692.31 $ 96.040  Million 182 
Sanuwave Health Inc   508,163.64 $ 27.949  Million 55 
Eli Lilly And Company  505,534.00 $ 25,276.700  Million 50,000 
Incyte Corporation  503,437.76 $ 1,431.777  Million 2,844 
Harmony Biosciences Holdings inc   496,979.52 $ 145.615  Million 293 
Omeros Corporation  492,400.00 $ 86.170  Million 175 
Acadia Pharmaceuticals Inc   470,739.35 $ 375.650  Million 798 
Siga Technologies Inc  412,920.69 $ 20.233  Million 49 
Black Hawk Acquisition Corporation  405,491.50 $ 0.811  Million
Neurocrine Biosciences Inc   334,300.00 $ 668.600  Million 2,000 


Date modified: 2026-08-29T17:50:16+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.